FDA Class II Recall Hits 51,762 Units of ORL Labs Oral Care Products Over Hormone Contamination

3 min read
Source: New York Post
FDA Class II Recall Hits 51,762 Units of ORL Labs Oral Care Products Over Hormone Contamination
Photo: New York Post
TL;DR

The U.S. Food and Drug Administration (FDA) has classified a voluntary recall of 51,762 units of ORL Labs LLC oral care products as Class II after testing detected hormones in samples. The recall, initiated on October 12, 2026, and classified on November 6, 2026, affects six toothpaste and mouthwash products for adults and children. The FDA did not specify hormone concentrations or the cause of cross-contamination, and no illnesses have been reported.

Key points

  • ORL Labs LLC, based in Scottsdale, Arizona, voluntarily recalled 51,762 units of six ORL Organic Oral Care products after the FDA detected progesterone, estradiol, or dehydroepiandrosterone (DHEA) in samples.
  • The recall was initiated on October 12, 2026, and classified as Class II by the FDA on November 6, 2026. A Class II recall indicates that exposure may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote.
  • Affected products include 4-ounce tubes of toothpaste in Fresh Mint (19,247 units), Cinnamint (7,202 units), and Bubblegum Kids (3,976 units), as well as 16.9-ounce bottles of mouthwash in Fresh Mint (12,081 units), Cinnamint Kids (6,140 units), and Bubblegum Kids (3,116 units).
  • The FDA report did not specify which hormones or concentrations were detected in individual samples, nor did it explain how the cross-contamination occurred. No illnesses have been reported in connection with the products.
  • Affected products carry expiration dates between September 2026 and August 2028. Specific lot numbers are listed in the FDA enforcement report. ORL Labs notified consignees and the public by letter but did not issue a press release or provide specific disposal or refund instructions.

Background

This recall follows a pattern of FDA Class II recalls for consumer products in 2026, including a September 2026 recall of Miyoko's plant butter over E. coli and mold concerns. ORL Labs' recall is part of ongoing FDA efforts to ensure product safety and transparency, particularly for items marketed to children.

How outlets are covering it

All sources (New York Post, Fox Business, WCVB, USA Today) report the same core facts: 51,762 units recalled, Class II classification, hormone detection, and lack of specific details on concentrations or contamination cause. USA Today provides the most detailed list of affected lot numbers. No source reports illnesses or specific disposal instructions. ORL Labs did not respond to comment requests from any outlet.

Why it matters

The recall highlights potential cross-contamination risks in oral care products, particularly those marketed to children. While the FDA classifies the risk as remote, the presence of hormones like progesterone and estradiol in toothpaste and mouthwash raises concerns about unintended exposure. Consumers are advised to check lot numbers and expiration dates against the FDA report and contact ORL Labs for questions.

What to watch

Consumers should check their ORL Labs products against the FDA enforcement report for affected lot numbers and expiration dates. ORL Labs may issue further guidance on disposal or refunds. The FDA may investigate the cause of the cross-contamination, though no timeline has been announced.

Share this article

Want the full story? Read the original reporting

Read on New York Post